Clinical Trial Supply and Logistics Market experiences disruptions due to introduction of new stem cell therapies for treatment of Covid-19

The clinical trial supply and logistics market is expected to witness significant growth in the near future. With such a large volume of clinical trial supply being created each year, the industry is seeing rapid growth. However, there are challenges faced by the companies that operate in this industry, as well as those conducting clinical trials. These challenges include the impact of regulations on both the supply-chain management systems and the industry itself. While the FDA sets the standards for what the clinical trial supply industry needs to perform, the supply chain management systems have to adapt to the ever-changing regulations in the healthcare sector.

Click Here To Get Sample Copy @ https://www.coherentmarketinsights.com/insight/request-sample/1798

Emergence of Covid-19 has significantly impacted growth of the clinical trial supply and logistics market. Globally, as of 10:12am CEST, 30 June 2021, there have been 181,344,224 confirmed cases of COVID-19, including 3,934,252 deaths, reported to WHO. As of 28 June 2021, a total of 2,660,756,547 vaccine doses have been administered. According to the Ssecretary of the Department of Biotechnology, Renu Swarup, vaccine candidates from Zydus Cadila, Gennova, Bharat Biotech (single dose intranasal vaccine) and Biological E are being provided nearly US$ 54 million as financial support.

On the supply-chain side of the industry, the outlook of the clinical trial supply and logistics market for pharma industries is positive. Demand for the products is increasing, especially in areas such as diabetes and asthma. Demand is projected to continue growing, especially in the USA, where an estimated 66% of the population is suffering from some kind of chronic health condition. Another area of great demand is oral diseases such as Alzheimer's and Parkinson's disease. Due to the aging population in the USA, the demand for prevention and treatments of these diseases will continue to grow.

Due to the recent developments in the pharmaceutical sector, there is a great deal of interest in the therapeutic area. Two major areas have become important providers of medical services. These include immunology and biotechnology. Immunology addresses the management of diseases associated with the immune system. Biotechnology applies the principles of genetic engineering to improve the development of medicines.

The clinical trial supply and logistics market is currently experiencing new disruptions due to the introduction of new stem cell therapies for the treatment of Covid-19. In November 2020, the randomized, controlled Phase III trial of remestemcel-L in patients with moderate to severe acute respiratory distress syndrome (ARDS) due to COVID-19 infection has been advised to continue by the independent Data Safety Monitoring Board (DSMB).

Key Players

Some of the key players operating in the global clinical trial supply and logistics market include Catalent Pharma Solutions, Inc., Almac Group, Movianto, Patheon, Inc., PCI Pharma Distribution, Sharp Packaging Distribution, PAREXEL International Corporation, Marken, KLIFO A/S, and Biocair.

LIMITED TIME OFFER – Hurry Up!
Exclusive offer!!! Purchase the report at a discounted rate!!!

Buy Now with Discount for Premium Report (Flat US $ 2000 Off) : https://www.coherentmarketinsights.com/promo/buynow/1798

Contact Us

Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Phone: US +12067016702 / UK +4402081334027
Email: sales@coherentmarketinsights.com

About Coherent Market Insights

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

This release was published on openPR.